HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AMPA-preferring receptors mediate excitatory non-NMDA responses of primate retinal ganglion cells.

Abstract
Glutamate and kainate-induced currents of primate ganglion cells were studied using the whole-cell patch-clamp technique in a retinal slice preparation. Antagonists and allosteric modulators of desensitization selective for either alpha-amino-3-hydroxy-5-methyl-4-isoazoleprionic acid (AMPA)- or kainate-preferring receptors were used to determine the contributions of each type of receptor to excitatory responses. With synaptic transmission and NMDA receptors blocked, the AMPA-preferring receptor antagonist GYKI 52466 (30 microM-100 microM) reversibly blocked most of the glutamate-induced current in ganglion cells. GYKI 52466 also blocked the response in ganglion cells to focally applied kainate, suggesting that the current response to kainate arises from activation of AMPA-preferring receptors, and not kainate-preferring receptors. Both cyclothiazide (10 microM-100 microM) and the novel drug 4-[2-(phenylsulfonylamino)ethylthio]-2,6-difluoro-phenoxyacetamide (PEPA, 20 microM-100 microM), which selectively enhance responses mediated by AMPA-preferring receptors, enhanced glutamate-induced responses of ganglion cells. Since these drugs preferentially inhibit desensitization of the flip and flop splice variants, respectively, of AMPA-preferring receptors, it is likely that both splice variants are present on these ganglion cells. Concanavalin A, which selectively suppresses the desensitization of kainate-preferring receptors, had no effect on the glutamate-induced responses of ganglion cells. We conclude that the non-NMDA component of the excitatory, glutamatergic input to primate ganglion cells is mediated largely by AMPA-preferring receptors, with little, if any, kainate-preferring receptor-mediated response.
AuthorsR A Jacoby, S M Wu
JournalVisual neuroscience (Vis Neurosci) 2001 Sep-Oct Vol. 18 Issue 5 Pg. 703-10 ISSN: 0952-5238 [Print] England
PMID11925006 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • 4-(2-(phenylsulfonylamino)ethylthio)-2,6-difluorophenoxyacetamide
  • Anti-Anxiety Agents
  • Benzothiadiazines
  • Excitatory Amino Acid Antagonists
  • Phenoxyacetates
  • Receptors, AMPA
  • Receptors, Kainic Acid
  • Receptors, N-Methyl-D-Aspartate
  • GYKI 52466
  • Benzodiazepines
  • Glutamic Acid
  • cyclothiazide
  • Kainic Acid
Topics
  • Animals
  • Anti-Anxiety Agents (pharmacology)
  • Benzodiazepines
  • Benzothiadiazines (pharmacology)
  • Excitatory Amino Acid Antagonists (pharmacology)
  • Glutamic Acid (pharmacology)
  • Kainic Acid (pharmacology)
  • Macaca mulatta
  • Papio
  • Patch-Clamp Techniques
  • Phenoxyacetates (pharmacology)
  • Receptors, AMPA (antagonists & inhibitors, metabolism)
  • Receptors, Kainic Acid (antagonists & inhibitors, metabolism)
  • Receptors, N-Methyl-D-Aspartate (metabolism)
  • Retinal Ganglion Cells (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: